Загрузка...
Inflammasomes: a novel therapeutic target in pulmonary hypertension?
Pulmonary hypertension (PH) is a rare, progressive pulmonary vasculopathy characterized by increased mean pulmonary arterial pressure, pulmonary vascular remodelling and right ventricular failure. Current treatments are not curative, and new therapeutic strategies are urgently required. Clinical and...
Сохранить в:
| Опубликовано в: : | Br J Pharmacol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6534811/ https://ncbi.nlm.nih.gov/pubmed/29847700 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14375 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|